An overall protective effect of antipsychotic drugs against COVID-19 seems implausible.

Ruiz de Pellón-Santamaría, Ángel; Sarasqueta-Eizaguirre, Cristina; Basterrechea-Peña, Francisco Javier

Ruiz de Pellón-Santamaría, Ángel; Sarasqueta-Eizaguirre, Cristina; Basterrechea-Peña, Francisco Javier.

Ruiz de Pellón-Santamaría Á; Department of Psychiatry, Donostia University Hospital, Paseo Doctor Begiristain, s/n, 20014 Donostia, Guipúzcoa, Spain. Electronic address: ANGEL.RUIZDEPELLONSANTAMARIA@osakidetza.eus.
Sarasqueta-Eizaguirre C; Information and Healthcare Results Unit (UNIRA), Donostia University Hospital, Paseo Doctor Begiristain, s/n, 20014 Donostia, Guipúzcoa, Spain; BioDonostia Research Institute, Paseo Doctor Begiristain, s/n, 20014 Donostia, Guipúzcoa, Spain. Electronic address: CRISTINA.SARASQUETAEIZAGUIRRE@osakidetza.eus.
Basterrechea-Peña FJ; Information and Healthcare Results Unit (UNIRA), Donostia University Hospital, Paseo Doctor Begiristain, s/n, 20014 Donostia, Guipúzcoa, Spain. Electronic address: FRANCISCOJAVIER.BASTERRECHEAPENA@osakidetza.eus.

Schizophr Res ; 243: 486-488, 2022 05.

Article in English | MEDLINE | ID: covidwho-1586565

Subject(s)

Antipsychotic Agents; Bipolar Disorder; COVID-19; Schizophrenia; Antipsychotic Agents/therapeutic use; Bipolar Disorder/drug therapy; Delayed-Action Preparations/therapeutic use; Humans; Schizophrenia/drug therapy

Keywords

Age; Bipolar; COVID-19; LAI antipsychotics; SARS-CoV-2; Schizophrenia; Severe mental disorder

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Bipolar Disorder / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Schizophr Res Journal subject: Psychiatry Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google